Please login to the form below

Not currently logged in
Email:
Password:

norovirus

This page shows the latest norovirus news and features for those working in and with pharma, biotech and healthcare.

UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’

UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’

Human challenge studies have been used previously to support the development of treatments for a range of disease, including malaria, typhoid, cholera, norovirus and influenza.

Latest news

  • Takeda starts trial of norovirus vaccine Takeda starts trial of norovirus vaccine

    There is no drug treatment available, so management of norovirus focuses on preventing transmission and supportive care for those infected. ... It includes antigens from norovirus genotypes GI.1 and GII.4, which are thought to cause the majority of human

  • Germinating virologists

    The aim is to exploit the expertise he has built up in generating Naked Scientist to increase public knowledge in microbiology on issues such as C difficile, norovirus and MRSA.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2012 Pharma deals during October 2012

    LigoCyte has a number of vaccine products in development, including its lead candidate, which is in phase I/II vaccine to prevent norovirus gastroenteritis, commonly known as winter vomiting disease.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...